Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets
Report Scope:
This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.
Report Includes:
This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.
Report Includes:
- 43 data tables and 66 additional tables
- An overview of the global markets for gastrointestinal disease (GI) therapeutics and diagnostics.
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
- Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
- Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
- Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
- A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
- Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies’ ESG scores, and the ESG practices followed by leading companies.
- Information pertaining to the recent developments and emerging technologies in the market.
- Review of current and potential treatment options and their impact on this market growth.
- A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
- An analysis of the competitive landscape based on recent developments and segmental revenues.
- Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Highlights of the Global Market for GI Therapeutics and Diagnostics
CHAPTER 2 MARKET OVERVIEW
Overview of the Gastrointestinal System
Physiology of the GI System and the Role of Each Part in the GI Process
CHAPTER 3 MARKET DYNAMICS
Drivers
Increasing Prevalence of GI Cancer
Increasing Prevalence of GI Disorders
Growing Trend toward Screening and Preventive Care
Growing Adoption and Approval of Biological Drugs
High Unmet Need
Challenges
Loss of Exclusivity and Genericization
Regulatory and Safety Issues
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Incorporation of AI and Other Digital Technologies
Single-Use Endoscopes
Focus on Biologics
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Global Market for Prescription GI Therapeutics, by Drug Type
Anti-inflammatories for Bowel Diseases
Gastrointestinal Cancer
Proton Pump Inhibitors
Anti-diarrheals
Others
Global Market for Prescription GI Drugs, by Type
Anti-inflammatories for Bowel Diseases
Gastrointestinal Cancer Therapeutics
Proton Pump Inhibitors
Anti-diarrheals
Others
Trends in the Market for Prescription GI Drugs
Global Market for Over-the-Counter GI Drugs, by Drug Type
Laxatives
Antacids
Proton Pump Inhibitors
Histamine-2 Blockers and Inhibitors
Anti-diarrheals
Global Market for Over-the-Counter GI Drugs, by Type
Laxatives
Antacids
Proton Pump Inhibitors
Histimine-2 Blockers
Anti-diarrheals
Opportunities in the Market of Over-the-Counter GI Medications
Global Market for Gastrointestinal Endoscopy Equipment
GI Endoscopes and Visualization Systems
GI Endotherapy Devices
Global Market for GI Endoscopy Equipment, by Product
Technological Trends in the Market for GI Endoscopy
Global Market for GI Endoscopy Equipment, by Region
North America
Europe
Asia-Pacific
Rest of the World
Opportunities in the Market for GI Endoscopy Equipment
Global Market for GI Vaccines
Rotavirus Vaccine
Hepatitis
Hepatitis Vaccine
Global Market for GI Vaccines, by Disease Type
Global Market for Rotavirus Vaccines, by Region
Global Market for Hepatitis Vaccines by Region
Geographic Breakdown
Global Market for GI Therapeutics and Diagnostics, by Region
Market Revenue, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 6 COMPETITIVE INTELLIGENCE
Overview
Over-the-Counter GI Drugs
Prescription GI Drugs
GI Endoscopy Equipment
GI Vaccines
GI Disease Types
Disease Types
Inflammatory Bowel Diseases
GI Cancer
Gastroesophageal Reflux Disease
CHAPTER 7 APPENDIX
Methodology and Information Sources
Company Profiles
ABBVIE INC.
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GSK PLC
HALEON GROUP OF CO.
JOHNSON & JOHNSON SERVICES INC.
OLYMPUS CORP.
PROCTER & GAMBLE
SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
Market Outlook
Scope of Report
Highlights of the Global Market for GI Therapeutics and Diagnostics
CHAPTER 2 MARKET OVERVIEW
Overview of the Gastrointestinal System
Physiology of the GI System and the Role of Each Part in the GI Process
CHAPTER 3 MARKET DYNAMICS
Drivers
Increasing Prevalence of GI Cancer
Increasing Prevalence of GI Disorders
Growing Trend toward Screening and Preventive Care
Growing Adoption and Approval of Biological Drugs
High Unmet Need
Challenges
Loss of Exclusivity and Genericization
Regulatory and Safety Issues
CHAPTER 4 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Overview
Incorporation of AI and Other Digital Technologies
Single-Use Endoscopes
Focus on Biologics
CHAPTER 5 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Global Market for Prescription GI Therapeutics, by Drug Type
Anti-inflammatories for Bowel Diseases
Gastrointestinal Cancer
Proton Pump Inhibitors
Anti-diarrheals
Others
Global Market for Prescription GI Drugs, by Type
Anti-inflammatories for Bowel Diseases
Gastrointestinal Cancer Therapeutics
Proton Pump Inhibitors
Anti-diarrheals
Others
Trends in the Market for Prescription GI Drugs
Global Market for Over-the-Counter GI Drugs, by Drug Type
Laxatives
Antacids
Proton Pump Inhibitors
Histamine-2 Blockers and Inhibitors
Anti-diarrheals
Global Market for Over-the-Counter GI Drugs, by Type
Laxatives
Antacids
Proton Pump Inhibitors
Histimine-2 Blockers
Anti-diarrheals
Opportunities in the Market of Over-the-Counter GI Medications
Global Market for Gastrointestinal Endoscopy Equipment
GI Endoscopes and Visualization Systems
GI Endotherapy Devices
Global Market for GI Endoscopy Equipment, by Product
Technological Trends in the Market for GI Endoscopy
Global Market for GI Endoscopy Equipment, by Region
North America
Europe
Asia-Pacific
Rest of the World
Opportunities in the Market for GI Endoscopy Equipment
Global Market for GI Vaccines
Rotavirus Vaccine
Hepatitis
Hepatitis Vaccine
Global Market for GI Vaccines, by Disease Type
Global Market for Rotavirus Vaccines, by Region
Global Market for Hepatitis Vaccines by Region
Geographic Breakdown
Global Market for GI Therapeutics and Diagnostics, by Region
Market Revenue, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 6 COMPETITIVE INTELLIGENCE
Overview
Over-the-Counter GI Drugs
Prescription GI Drugs
GI Endoscopy Equipment
GI Vaccines
GI Disease Types
Disease Types
Inflammatory Bowel Diseases
GI Cancer
Gastroesophageal Reflux Disease
CHAPTER 7 APPENDIX
Methodology and Information Sources
Company Profiles
ABBVIE INC.
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GSK PLC
HALEON GROUP OF CO.
JOHNSON & JOHNSON SERVICES INC.
OLYMPUS CORP.
PROCTER & GAMBLE
SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
LIST OF TABLES
Summary Table : Global Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 1 : Estimated New GI Cancer Cases, by Cancer Site, 2020–2040
Table 2 : Common GI Conditions Prevalence
Table 3 : First-Time Biosimilar and Generic Approvals for GI Drugs, October 2022–January 2023
Table 4 : Artificial Intelligence Applications in GI Disease Diagnostics and Therapeutics
Table 5 : Artificial Intelligence-Powered Gastrointestinal Lesion Software Detection System
Table 6 : Artificial Intelligence-Related Acquisitions and Collaborations in the GI Drug and Diagnostics Market, 2023
Table 7 : Inflammatory Bowel Disease Types
Table 8 : Prevalence of Inflammatory Bowel Disease, 2023
Table 9 : Selected Anti-inflammatory Prescription Drugs for Inflammatory Bowel Diseases
Table 10 : Common GI Cancers, 2020
Table 11 : Selected FDA-Approved Drugs for GI Cancer Treatment
Table 12 : Selected Prescription Proton Pump Inhibitors
Table 13 : Selected Prescription Anti-diarrheals
Table 14 : Other Functional Bowel Disorder Agents
Table 15 : Global Market for Prescription GI Drugs, by Type, Through 2028
Table 16 : Global Market for Anti-inflammatory Drugs for Bowel Disease, by Region, Through 2028
Table 17 : Global Market for GI Cancer Therapeutics, by Region, Through 2028
Table 18 : Global Market for Prescription Proton Pumpers, by Region, Through 2028
Table 19 : Global Market for Prescription Anti-diarrheals, by Region, Through 2028
Table 20 : Global Market for Other Types of Prescription GI Drugs, by Region, Through 2028
Table 21 : Selected Over-the-Counter Laxatives
Table 22 : Selected Over-the-Counter Antacids
Table 23 : Selected Over-the-Counter Proton Pump Inhibitors
Table 24 : Selected Over-the-Counter Histamine-2 Blockers
Table 25 : Over-the-Counter Proton Pump Inhibitors versus Histamine-2 Inhibitors Versus Antacids
Table 26 : Over-the-Counter Options Available for Heartburn
Table 27 : Selected Over-the-Counter Anti-diarrheals
Table 28 : Global Market for Over-the-Counter GI Drugs, by Type, Through 2028
Table 29 : Global Market for Laxatives, by Region, Through 2028
Table 30 : Global Market for Antacids, by Region, Through 2028
Table 31 : Global Market for Over-the-Counter Proton Pump Inhibitors, by Region, Through 2028
Table 32 : Global Market for Histimine-2 Inhibitors, by Region, Through 2028
Table 33 : Global Market for Over-the-Counter Anti-diarrheals, by Region, Through 2028
Table 34 : Therapeutic Uses of GI Endoscopy
Table 35 : Selected GI Conditions
Table 36 : Global Market for GI Endoscopy Equipment, by Product, Through 2028
Table 37 : Commercially Available Capsule Endoscope
Table 38 : Global Market for GI Endoscopy Equipment, by Region, Through 2028
Table 39 : North American Market for GI Endoscopy Equipment, by Product, Through 2028
Table 40 : Selected European Countries Health Spending Per Capita Growth, 2010–2020
Table 41 : European Market for GI Endoscopy Equipment, by Product, Through 2028
Table 42 : Asia-Pacific Market for GI Endoscopy Equipment, by Product, Through 2028
Table 43 : RoW Market for GI Endoscopy Equipment, by Product, Through 2028
Table 44 : Rotavirus Vaccines
Table 45 : Hepatitis Types
Table 46 : Hepatitis Vaccines
Table 47 : Global Market for GI Vaccines, by Disease Type, Through 2028
Table 48 : Global Market for Rotavirus Vaccines, by Region, Through 2028
Table 49 : Global Market for Hepatitis Vaccines, by Region, Through 2028
Table 50 : Global Market for GI Therapeutics and Diagnostics, by Region, Through 2028
Table 51 : North American Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 52 : European Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 53 : Estimated Population and GI Cancer Cases, by Region, 2020 and 2040
Table 54 : Asia-Pacific Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 55 : RoW Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 56 : Global Company Ranking in the Market for Over-the-Counter GI Drugs, 2022
Table 57 : Global Company Ranking in the Market for Anti-inflammatory Drugs for Bowel Diseases, 2022
Table 58 : Global Company Ranking in the Market for GI Cancer Drugs, 2022
Table 59 : Leading Companies in the Number of Phase III Clinical Trials on IBD Drugs
Table 60 : Leading Companies in the Number of Phase III Clinical Trials on GI Cancer Drugs
Table 61 : Leading Companies in the Number of Phase III Clinical Trials on GERD Drugs
Table 62 : Acronyms
Table 63 : AbbVie Inc.: Company Snapshot
Table 64 : AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 65 : AbbVie Inc.: Product Portfolio
Table 66 : Abbvie Inc.: News/Key Developments, 2022-2023
Table 67 : Bayer AG: Company Snapshot
Table 68 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 69 : Bayer AG: Product Portfolio
Table 70 : Bayer AG: News/Key Developments, 2023
Table 71 : Boston Scientific Corp.: Company Snapshot
Table 72 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 73 : Boston Scientific Corp.: Product Portfolio
Table 74 : Boston Scientific Corp.: News/Key Developments, 2023
Table 75 : Bristol-Myers Squibb Co.: Company Snapshot
Table 76 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 77 : Bristol-Myers Squibb Co.: Product Portfolio
Table 78 : Bristol-Myers Squibb Co.: News/Key Developments, 2022
Table 79 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 80 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 81 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 82 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022 and 2023
Table 83 : GSK PLC: Company Snapshot
Table 84 : GSK PLC: Financial Performance, FY 2022 and 2023
Table 85 : GSK PLC: Product Portfolio
Table 86 : Haleon Group of Co.: Company Snapshot
Table 87 : Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 88 : Haleon Group of Co.: Product Portfolio
Table 89 : Haleon Group of Co.: News/Key Developments, 2022
Table 90 : Johnson & Johnson Services Inc.: Company Snapshot
Table 91 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 92 : Johnson & Johnson Services Inc.: Product Portfolio
Table 93 : Johnson & Johnson Services Inc.: News/Key Developments, 2022 and 2023
Table 94 : Olympus Corp.: Company Snapshot
Table 95 : Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 96 : Olympus Corp.: Product Portfolio
Table 97 : Olympus Corp.: News/Key Developments, 2022-2023
Table 98 : Procter & Gamble: Company Snapshot
Table 99 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100 : Procter & Gamble: Product Portfolio
Table 101 : Sanofi: Company Snapshot
Table 102 : Sanofi: Financial Performance, FY 2022 and 2023
Table 103 : Sanofi: Product Portfolio
Table 104 : Sanofi: News/Key Developments, 2022-2023
Table 105 : Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 106 : Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 107 : Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 108 : Takeda Pharmaceutical Co. Ltd.: Key Developments, 2022-2023
Summary Table : Global Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 1 : Estimated New GI Cancer Cases, by Cancer Site, 2020–2040
Table 2 : Common GI Conditions Prevalence
Table 3 : First-Time Biosimilar and Generic Approvals for GI Drugs, October 2022–January 2023
Table 4 : Artificial Intelligence Applications in GI Disease Diagnostics and Therapeutics
Table 5 : Artificial Intelligence-Powered Gastrointestinal Lesion Software Detection System
Table 6 : Artificial Intelligence-Related Acquisitions and Collaborations in the GI Drug and Diagnostics Market, 2023
Table 7 : Inflammatory Bowel Disease Types
Table 8 : Prevalence of Inflammatory Bowel Disease, 2023
Table 9 : Selected Anti-inflammatory Prescription Drugs for Inflammatory Bowel Diseases
Table 10 : Common GI Cancers, 2020
Table 11 : Selected FDA-Approved Drugs for GI Cancer Treatment
Table 12 : Selected Prescription Proton Pump Inhibitors
Table 13 : Selected Prescription Anti-diarrheals
Table 14 : Other Functional Bowel Disorder Agents
Table 15 : Global Market for Prescription GI Drugs, by Type, Through 2028
Table 16 : Global Market for Anti-inflammatory Drugs for Bowel Disease, by Region, Through 2028
Table 17 : Global Market for GI Cancer Therapeutics, by Region, Through 2028
Table 18 : Global Market for Prescription Proton Pumpers, by Region, Through 2028
Table 19 : Global Market for Prescription Anti-diarrheals, by Region, Through 2028
Table 20 : Global Market for Other Types of Prescription GI Drugs, by Region, Through 2028
Table 21 : Selected Over-the-Counter Laxatives
Table 22 : Selected Over-the-Counter Antacids
Table 23 : Selected Over-the-Counter Proton Pump Inhibitors
Table 24 : Selected Over-the-Counter Histamine-2 Blockers
Table 25 : Over-the-Counter Proton Pump Inhibitors versus Histamine-2 Inhibitors Versus Antacids
Table 26 : Over-the-Counter Options Available for Heartburn
Table 27 : Selected Over-the-Counter Anti-diarrheals
Table 28 : Global Market for Over-the-Counter GI Drugs, by Type, Through 2028
Table 29 : Global Market for Laxatives, by Region, Through 2028
Table 30 : Global Market for Antacids, by Region, Through 2028
Table 31 : Global Market for Over-the-Counter Proton Pump Inhibitors, by Region, Through 2028
Table 32 : Global Market for Histimine-2 Inhibitors, by Region, Through 2028
Table 33 : Global Market for Over-the-Counter Anti-diarrheals, by Region, Through 2028
Table 34 : Therapeutic Uses of GI Endoscopy
Table 35 : Selected GI Conditions
Table 36 : Global Market for GI Endoscopy Equipment, by Product, Through 2028
Table 37 : Commercially Available Capsule Endoscope
Table 38 : Global Market for GI Endoscopy Equipment, by Region, Through 2028
Table 39 : North American Market for GI Endoscopy Equipment, by Product, Through 2028
Table 40 : Selected European Countries Health Spending Per Capita Growth, 2010–2020
Table 41 : European Market for GI Endoscopy Equipment, by Product, Through 2028
Table 42 : Asia-Pacific Market for GI Endoscopy Equipment, by Product, Through 2028
Table 43 : RoW Market for GI Endoscopy Equipment, by Product, Through 2028
Table 44 : Rotavirus Vaccines
Table 45 : Hepatitis Types
Table 46 : Hepatitis Vaccines
Table 47 : Global Market for GI Vaccines, by Disease Type, Through 2028
Table 48 : Global Market for Rotavirus Vaccines, by Region, Through 2028
Table 49 : Global Market for Hepatitis Vaccines, by Region, Through 2028
Table 50 : Global Market for GI Therapeutics and Diagnostics, by Region, Through 2028
Table 51 : North American Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 52 : European Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 53 : Estimated Population and GI Cancer Cases, by Region, 2020 and 2040
Table 54 : Asia-Pacific Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 55 : RoW Market for GI Therapeutics and Diagnostics, by Product Type, Through 2028
Table 56 : Global Company Ranking in the Market for Over-the-Counter GI Drugs, 2022
Table 57 : Global Company Ranking in the Market for Anti-inflammatory Drugs for Bowel Diseases, 2022
Table 58 : Global Company Ranking in the Market for GI Cancer Drugs, 2022
Table 59 : Leading Companies in the Number of Phase III Clinical Trials on IBD Drugs
Table 60 : Leading Companies in the Number of Phase III Clinical Trials on GI Cancer Drugs
Table 61 : Leading Companies in the Number of Phase III Clinical Trials on GERD Drugs
Table 62 : Acronyms
Table 63 : AbbVie Inc.: Company Snapshot
Table 64 : AbbVie Inc.: Financial Performance, FY 2022 and 2023
Table 65 : AbbVie Inc.: Product Portfolio
Table 66 : Abbvie Inc.: News/Key Developments, 2022-2023
Table 67 : Bayer AG: Company Snapshot
Table 68 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 69 : Bayer AG: Product Portfolio
Table 70 : Bayer AG: News/Key Developments, 2023
Table 71 : Boston Scientific Corp.: Company Snapshot
Table 72 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 73 : Boston Scientific Corp.: Product Portfolio
Table 74 : Boston Scientific Corp.: News/Key Developments, 2023
Table 75 : Bristol-Myers Squibb Co.: Company Snapshot
Table 76 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 77 : Bristol-Myers Squibb Co.: Product Portfolio
Table 78 : Bristol-Myers Squibb Co.: News/Key Developments, 2022
Table 79 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 80 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 81 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 82 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022 and 2023
Table 83 : GSK PLC: Company Snapshot
Table 84 : GSK PLC: Financial Performance, FY 2022 and 2023
Table 85 : GSK PLC: Product Portfolio
Table 86 : Haleon Group of Co.: Company Snapshot
Table 87 : Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 88 : Haleon Group of Co.: Product Portfolio
Table 89 : Haleon Group of Co.: News/Key Developments, 2022
Table 90 : Johnson & Johnson Services Inc.: Company Snapshot
Table 91 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 92 : Johnson & Johnson Services Inc.: Product Portfolio
Table 93 : Johnson & Johnson Services Inc.: News/Key Developments, 2022 and 2023
Table 94 : Olympus Corp.: Company Snapshot
Table 95 : Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 96 : Olympus Corp.: Product Portfolio
Table 97 : Olympus Corp.: News/Key Developments, 2022-2023
Table 98 : Procter & Gamble: Company Snapshot
Table 99 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100 : Procter & Gamble: Product Portfolio
Table 101 : Sanofi: Company Snapshot
Table 102 : Sanofi: Financial Performance, FY 2022 and 2023
Table 103 : Sanofi: Product Portfolio
Table 104 : Sanofi: News/Key Developments, 2022-2023
Table 105 : Takeda Pharmaceutical Co. Ltd.: Company Snapshot
Table 106 : Takeda Pharmaceutical Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 107 : Takeda Pharmaceutical Co. Ltd.: Product Portfolio
Table 108 : Takeda Pharmaceutical Co. Ltd.: Key Developments, 2022-2023
LIST OF FIGURES
Summary Figure : Global Market Shares of GI Therapeutics and Diagnostics, by Product Type, 2022
Figure 1 : Market Dynamics of Gastrointestinal Therapeutics and Diagnostics
Figure 2 : Estimated New GI Cancer Cases, by Cancer Type, 2020–2040
Figure 3 : Emerging Trends and Technologies in Gastrointestinal Care
Figure 4 : Five-Year Overall Survival Rates in the U.S., by GI Cancer Type, 2022
Figure 5 : Global Market Shares of Prescription GI Drugs, by Type, 2022
Figure 6 : Trends in the Market for Prescription GI Drugs
Figure 7 : Market Drivers in the Market for Over-the-Counter GI Drugs
Figure 8 : Global Market for Over-the-Counter GI Drugs, by Type, 2020–2028
Figure 9 : Global Market Shares of Over-the-Counter GI Drugs, by Type, 2022
Figure 10 : Opportunities in the Market of Over-the-Counter GI Medications
Figure 11 : Global Market Shares of GI Endoscopy Equipment, by Product, 2022
Figure 12 : Global Market Shares of GI Endoscopy Equipment, by Region, 2022
Figure 13 : Opportunities in the Market for GI Endoscopy
Figure 14 : Global Market Shares of GI Vaccines, by Disease Type, 2022
Figure 15 : Global Market Shares of GI Therapeutics and Diagnostics, by Region, 2022
Figure 16 : Estimated Share of GI Cancer Cases, by Region, 2020 and 2040
Figure 17 : Global Market Shares of GI Endoscopy Equipment, by Leading Company, 2022
Figure 18 : Global Market Shares of GI Vaccines, by Leading Company, 2022
Figure 19 : Industry Sponsored Phase II or III Clinical Trials on GI Diseases, by Disease Type, December 2023
Figure 20 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2023
Figure 21 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2023
Figure 22 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 24 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 27 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 29 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 30 : GSK PLC: Revenue Share, by Business Unit, FY 2023
Figure 31 : GSK PLC: Revenue Share, by Country/Region, FY 2023
Figure 32 : Haleon Group of Co.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Haleon Group of Co.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Olympus Corp.: Revenue Share, by Business Unit, FY 2023
Figure 37 : Olympus Corp.: Revenue Share, by Country/Region, FY 2023
Figure 38 : Procter & Gamble: Revenue Share, by Business Unit, FY 2023
Figure 39 : Procter & Gamble: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sanofi: Revenue Share, by Country/ Region, FY 2023
Figure 42 : Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 43 : Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
Summary Figure : Global Market Shares of GI Therapeutics and Diagnostics, by Product Type, 2022
Figure 1 : Market Dynamics of Gastrointestinal Therapeutics and Diagnostics
Figure 2 : Estimated New GI Cancer Cases, by Cancer Type, 2020–2040
Figure 3 : Emerging Trends and Technologies in Gastrointestinal Care
Figure 4 : Five-Year Overall Survival Rates in the U.S., by GI Cancer Type, 2022
Figure 5 : Global Market Shares of Prescription GI Drugs, by Type, 2022
Figure 6 : Trends in the Market for Prescription GI Drugs
Figure 7 : Market Drivers in the Market for Over-the-Counter GI Drugs
Figure 8 : Global Market for Over-the-Counter GI Drugs, by Type, 2020–2028
Figure 9 : Global Market Shares of Over-the-Counter GI Drugs, by Type, 2022
Figure 10 : Opportunities in the Market of Over-the-Counter GI Medications
Figure 11 : Global Market Shares of GI Endoscopy Equipment, by Product, 2022
Figure 12 : Global Market Shares of GI Endoscopy Equipment, by Region, 2022
Figure 13 : Opportunities in the Market for GI Endoscopy
Figure 14 : Global Market Shares of GI Vaccines, by Disease Type, 2022
Figure 15 : Global Market Shares of GI Therapeutics and Diagnostics, by Region, 2022
Figure 16 : Estimated Share of GI Cancer Cases, by Region, 2020 and 2040
Figure 17 : Global Market Shares of GI Endoscopy Equipment, by Leading Company, 2022
Figure 18 : Global Market Shares of GI Vaccines, by Leading Company, 2022
Figure 19 : Industry Sponsored Phase II or III Clinical Trials on GI Diseases, by Disease Type, December 2023
Figure 20 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2023
Figure 21 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2023
Figure 22 : Bayer AG: Revenue Share, by Business Unit, FY 2023
Figure 23 : Bayer AG: Revenue Share, by Country/Region, FY 2023
Figure 24 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 25 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 26 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 27 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 28 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 29 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 30 : GSK PLC: Revenue Share, by Business Unit, FY 2023
Figure 31 : GSK PLC: Revenue Share, by Country/Region, FY 2023
Figure 32 : Haleon Group of Co.: Revenue Share, by Business Unit, FY 2023
Figure 33 : Haleon Group of Co.: Revenue Share, by Country/Region, FY 2023
Figure 34 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 35 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 36 : Olympus Corp.: Revenue Share, by Business Unit, FY 2023
Figure 37 : Olympus Corp.: Revenue Share, by Country/Region, FY 2023
Figure 38 : Procter & Gamble: Revenue Share, by Business Unit, FY 2023
Figure 39 : Procter & Gamble: Revenue Share, by Country/Region, FY 2023
Figure 40 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 41 : Sanofi: Revenue Share, by Country/ Region, FY 2023
Figure 42 : Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 43 : Takeda Pharmaceutical Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
